NOVELION THERAPEUTICS INC - COM NEW (NVLNF)

CUSIP: 67001K202

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM NEW
Total 13F shares
13,542,708
Share change
+555,038
Total reported value
$145,440,000
Put/Call ratio
0%
Price per share
$10.74
Number of holders
61
Value change
+$9,245,592
Number of buys
25
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 67001K202?
CUSIP 67001K202 identifies NVLNF - NOVELION THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVELION THERAPEUTICS INC - COM NEW (NVLNF) as of Q1 2017

As of 31 Mar 2017, NOVELION THERAPEUTICS INC - COM NEW (NVLNF) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,542,708 shares. The largest 10 holders included Broadfin Capital, LLC, ARMISTICE CAPITAL, LLC, Stonepine Capital Management, LLC, Sarissa Capital Management LP, Healthcare Value Capital, LLC, Opaleye Management Inc., HIGHBRIDGE CAPITAL MANAGEMENT LLC, KINGSTOWN CAPITAL MANAGEMENT L.P., FMR LLC, and Ancora Advisors, LLC. This page lists 61 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.